Library

Impact of 21st Century Cures Act

Congress recently passed the 21st Century Cures Act with $4.8 billion dollars in funding and a purpose of speeding the development and approval of new medicines and medical devices the act has generated significant excitement and discussion.  Some of the key components of the legislation include: $4.8 billion dollars additional...

Read More

Trending 2017: Talent War | Talent Strategies That Enable Innovation

The ability to attract and retain talent is increasingly becoming a top priority for companies. And within the life-sciences industry there is simply a stronger competitive environment in place for talent. Many are leaving large pharma for biotech companies, which are perceived to be more innovative and less bureaucratic. With...

Read More

How to Secure Intellectual Property from Loss or Compromise

Nate Lord  |  Tuesday January 10, 2017  |  Digital Guardian 28 data protection experts weigh in with tips on securing intellectual property in its many forms. Intellectual property is often among an organization’s most valuable assets, yet it’s also vulnerable to threat and compromise, particularly the vast amounts of intellectual...

Read More

State of the Art IT Portfolio Management…Isn’t Good Enough Anymore

Our previous article, Order from Chaos, The Building Blocks of Value Driven IT Portfolio Management, highlighted the pervasive problem of large enterprises having more proposed IT project investments than can be funded or staffed simultaneously.  Launching too many simultaneous projects results in slow progress, project overlaps and conflicts, and ultimately...

Read More

The 21st Century Cures Act: How will it impact today’s biggest pharma challenges?

Congress recently passed the 21st Century Cures Act with $4.8 billion dollars in funding and a purpose of speeding the development and approval of new medicines and medical devices.  The act has generated significant excitement and discussion.  Some of the key components of the legislation include: $4.8 billion dollars additional...

Read More

Transformation Strategy in the Face of Uncertainty: Planning for a Future that Thrives

This fall, TayganPoint hosted its annual Forum with three spectacular contributors, including Bob McMahon (Merck & Co.); Ricci Whitlow (G&W Laboratories) and Angela Johnson (Johnson & Johnson). Our esteemed speakers joined us for a lively discussion about planning for a future that thrives while living through the ups and downs...

Read More

Order from Chaos: The Building Blocks of Value Driven IT Portfolio Management

Most executives are familiar with the situation of having more proposed IT project investments than can be funded or staffed in a given budget cycle. Attempting to execute too many simultaneous projects spreads people and funding much too thinly across the initiatives, resulting in slow progress, project overlap, conflict, and...

Read More

Archives